Last update 21 Nov 2024
Evogliptin Tartrate/Metformin Hydrochloride
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Evogliptin/metformin, Sugamet + [1] |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (31 Dec 2015), |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC23H32F3N3O9 |
InChIKeyRBBXDAJRSNHIJZ-DLDKMZOSSA-N |
CAS Registry1222102-51-3 |
View All Structures (2)
Related
9
Clinical Trials associated with Evogliptin Tartrate/Metformin HydrochlorideAn Open Label, Randomized, Single Dose, Cross-over ,Two-group Study to Evaluate the Pharmacokinetics and Safety of DA-1229_01 5/1000mg in Healthy Subjects at Fed State
An Open Label, Randomized, Single Dose, Cross-over ,Two-group Study to Evaluate the Pharmacokinetics and Safety of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State
An Open Label, Randomized, Single Dose, Cross-over ,Two-group Study to Evaluate the Pharmacokinetics and Safety of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State
100 Clinical Results associated with Evogliptin Tartrate/Metformin Hydrochloride
Login to view more data
100 Translational Medicine associated with Evogliptin Tartrate/Metformin Hydrochloride
Login to view more data
100 Patents (Medical) associated with Evogliptin Tartrate/Metformin Hydrochloride
Login to view more data
100 Deals associated with Evogliptin Tartrate/Metformin Hydrochloride
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | KR | 31 Dec 2015 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 2 | KR | 01 Jul 2014 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | - | (iikfyzdfqt) = mkgwbfchmo vxmbkumrit (aendhobxct ) View more | - | 01 Jun 2021 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free